These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 19174316

  • 1. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
    Tomizawa A, Hattori Y, Suzuki K, Okayasu T, Kase H, Satoh H, Kasai K.
    Int J Cardiol; 2010 Sep 24; 144(1):108-9. PubMed ID: 19174316
    [No Abstract] [Full Text] [Related]

  • 2. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
    Hausberg M, Kosch M, Stam F, Heidenreich S, Kisters K, Rahn KH, Barenbrock M.
    Kidney Int; 2001 Apr 24; 59(4):1473-9. PubMed ID: 11260410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].
    Sergienko IV, Samoĭlenko EIu, Masenko VP, Ezhov MV, Sumarokov AB, Tkachev GA, Pogorelova OA, Balakhonova TV, Naumov VG.
    Kardiologiia; 2006 Apr 24; 46(5):4-8. PubMed ID: 16858347
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 24; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Update on statins.
    Mason P.
    J Vasc Nurs; 2004 Jun 24; 22(2):49-50. PubMed ID: 15179417
    [No Abstract] [Full Text] [Related]

  • 8. Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.
    Timár O, Szekanecz Z, Kerekes G, Végh J, Oláh AV, Nagy G, Csiki Z, Dankó K, Szamosi S, Németh Á, Soltész P, Szücs G.
    Arthritis Res Ther; 2013 Jun 24; 15(5):R105. PubMed ID: 24008003
    [Abstract] [Full Text] [Related]

  • 9. Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
    Qu HY, Xiao YW, Jiang GH, Wang ZY, Zhang Y, Zhang M.
    Pharm Res; 2009 Apr 24; 26(4):958-64. PubMed ID: 19082693
    [Abstract] [Full Text] [Related]

  • 10. Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.
    Kosch M, Barenbrock M, Suwelack B, Schaefer RM, Rahn KH, Hausberg M.
    Am J Kidney Dis; 2003 May 24; 41(5):1088-96. PubMed ID: 12722044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
    Samady H, McDaniel MC.
    JACC Cardiovasc Interv; 2009 Jul 24; 2(7):697-700. PubMed ID: 19628195
    [No Abstract] [Full Text] [Related]

  • 15. [Hypercholesterolemia, practical guidelines].
    Dallongeville J, Ferrières J, Schuster H, Farnier M, Lepen C.
    Presse Med; 2004 Sep 25; 33(16):1129-31. PubMed ID: 15523276
    [No Abstract] [Full Text] [Related]

  • 16. More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.
    Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K.
    Transplantation; 2014 Jun 27; 97(12):1266-71. PubMed ID: 24521776
    [Abstract] [Full Text] [Related]

  • 17. [Role of rosuvastatin in current lipid-lowering therapy].
    Abel T, Fehér J.
    Orv Hetil; 2010 Aug 29; 151(35):1424-8. PubMed ID: 20719717
    [Abstract] [Full Text] [Related]

  • 18. Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.
    Mindrescu C, Gupta RP, Hermance EV, DeVoe MC, Soma VR, Coppola JT, Staniloae CS.
    Vasc Health Risk Manag; 2008 Aug 29; 4(6):1439-47. PubMed ID: 19337557
    [Abstract] [Full Text] [Related]

  • 19. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.
    Leu HB, Chen JW, Wu TC, Ding YA, Lin SJ, Charng MJ.
    Clin Cardiol; 2005 Sep 29; 28(9):423-8. PubMed ID: 16250265
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment.
    Marino F, Maresca AM, Cosentino M, Castiglioni L, Rasini E, Mongiardi C, Maio RC, Legnaro M, Schembri L, Dentali F, Grandi AM, Guasti L.
    Cardiovasc Diabetol; 2012 Dec 22; 11():153. PubMed ID: 23259529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.